Aspira Pathlab & Diagnostics Limited (BOM:540788)

India · Delayed Price · Currency is INR

126.05

+2.60 (2.11%)

At close: Oct 23, 2026

Market Cap	1.30B +98.2%
Revenue (ttm)	259.03M +14.6%
Net Income	-4.08M
EPS	-0.41
Shares Out	10.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	352
Open	129.60
Previous Close	123.45
Day's Range	118.00 - 129.60
52-Week Range	49.00 - 149.99
Beta	0.48
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About BOM:540788

Aspira Pathlab & Diagnostics Limited owns, manages, runs, and administers various diagnostics centers primarily in India. The company offers biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigation services. It also provides pathology, sonography, x-ray, and radiology tests. The company was formerly known as Utkal Soap Products Limited and changed its name to Aspira Pathlab & Diagnostics Limited in November 2016. Aspira Pathlab & Diagnostics L... [Read more]

Industry Medical Laboratories

Founded 1973

Employees 168

Stock Exchange Bombay Stock Exchange

Ticker Symbol 540788

Full Company Profile

Financial Performance

In fiscal year 2026, BOM:540788's revenue was 249.82 million, an increase of 13.56% compared to the previous year's 219.99 million. Earnings were 513,000, a decrease of -97.52%.

Financial Statements